 |
| DNAP Presents Today at High-Level Conference CEYY Still Climbing |
|
 Hot Stock to Watch
|
Company: DNA Precious Metals Inc (OTCQB: DNAP)
|
End of Day:
Price: 0.47
Change (%): - 0.06 (11.32)
Volume: 3,305 |
 |
DNA Precious Metals Inc. to be Presenting at the 2013 Silver Summit Conference Today
MONTREAL, October 24, 2013 /PRNewswire/ - DNA Precious Metals Inc. (OTCQB: DNAP) (“DNA” or “the Company”) has been invited to speak at the 2013 Silver Summit conference in Spokane, Washington on Thursday, October 24, 2013 at 1:50pm am, Pacific time. The Silver Summit conference is a world premier event of among others, mining company executives and institutional investors, sponsored yearly by Cambridge House International. DNA Precious Metals is honored to participate in this important high-level conference where the Company will be presenting an update on its Montauban tailings mine production target of Q2 2014, and the acquisition of the Montauban gold silver zinc lead past producer, as well as strategy, results and upcoming plans.
Continue Reading
|
 Yesterday's Top Performer
|
Company: Fresh Start Private Management Inc. (OTCQB: CEYY) |
End of Day:
Price: 0.06
Change (%): + 0.01 (20.00)
Volume: 302,830 |
 |
Fresh Start Private Management, Inc. (OTCBB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.
Fresh Start Private’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.
Company Information Sheet |
Other Small Cap News
|
Company: Hemp, Inc. (Pink Sheets: HEMP)
|
The Medical Marijuana Controversy Continues as Actor Antonio Sabato, Jr. and Cheryl Shuman Face Off on Dr. Phil
LAS VEGAS, Oct. 24, 2013 /PRNewswire/ -- This week on Dr. Phil, two strong advocators for and against medical marijuana usage will come face-to-face to discuss a topic that has lingered in America for well over 50 years. The show will air on Friday, October 25, 2013. Antonio Sabata, Jr., known actor and model, is campaigning to ban the growth and distribution of medical marijuana in homes with children under the age of 18. To the contrary, Cheryl Shuman, who is well known in the medical marijuana industry will be defending her stance that everyone, regardless of age, should have access to medical marijuana and hemp-based cannabidiol products.
Agreeing with Cheryl Shuman, David Tobias said, "It's totally absurd that while the largest population in America being prescribed pharmaceutical drugs are children aged 4-18 that anybody would have the audacity to state that these same children should not have access to alternative, natural herbs and products such as medical marijuana when research has clearly shown the numerous benefits in curing and helping a wide range of medical conditions in this age group."
Continue Reading
|
Company: Medbox, Inc. (Pink Sheets: MDBX)
|
Medbox Poised for Significant Growth as New Gallup Poll Shows Majority of Americans Favor Legalization of Marijuana
Support surged 10 percentage points in past year, to 58%
WEST HOLLYWOOD, Calif., Oct. 24, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX), a leader in providing consulting services and patented systems to the medical and retail industries, stated that the company could see sharp revenue growth as a majority of Americans now favor the legalization of marijuana.
According to the Gallup Organization, for the first time ever, a clear majority of Americans (58%) say the drug should be legalized. This is in sharp contrast to the time Gallup first asked the question in 1969, when only 12% favored legalization.
Continue Reading |
Market News
|
By Ricardo Alonso-Zaldivar and Stephen Ohlemacher: Associated Press
|
Website contractors blame Obama administration
WASHINGTON (AP) - The principal contractors responsible for the federal government's trouble-plagued health insurance website say the Obama administration shares responsibility for the snags that have crippled the system.
Executives of CGI Federal, which built the federal HealthCare.gov website serving 36 states, and QSSI, which designed the part that verifies applicants' income and other personal details, are testifying Thursday before the House Energy and Commerce Committee.
The hearing comes as President Barack Obama's allies are starting to fret about the political fallout. Democrats had hoped to run for re-election next year on the benefits of the health care law for millions of uninsured Americans. Instead, computer problems are keeping many consumers from signing up through new online markets.
Continue Reading
|
By Lee Brodie: CNBC
|
Cramer: A stock with lots of ways to win
"I like nothing more than to find companies that give you lots of ways to win," Cramer said. "That's this stock, to a tee."
The Mad Money host was talking about Johnson & Johnson (JNJ), a stock that he suggests buying if the overall market declines.
All told, Cramer sees every reason for shares to climb. It's could attract growth investors, defensive investors, those looking for a spin-off and others betting on promising new treatments.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
